Search Within

Myeloma

Formats
  1. Meeting Abstract (557)
  2. Journal Article (368)
  3. Review (37)
  4. Research Letter (21)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (7)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (1016)
  2. Department of Medicine (1016)
  3. Hematologic Malignancies, Division of (1016)
  4. Hematologic Malignancies Research (669)
  5. Survivorship Research (374)
  6. Sloan Kettering Institute Postdocs (306)

More Groups

People
  1. Alexander Lesokhin (381)
  2. Hani Hassoun (339)
  3. Carl Landgren (336)
  4. Sham Mailankody (297)
  5. Malin Hultcrantz (274)
  6. Heather Landau (249)

More People

Years
  1. 2025 (28)
  2. 2024 (82)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (317)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (86)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (24)

More Publications

Publishers
  1. American Society of Hematology (340)
  2. Elsevier Inc. (160)
  3. American Society of Clinical Oncology (88)
  4. Nature Publishing Group (87)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (1016)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world effectiveness of approved anticancer agents among Medicare beneficiaries
    Meeting Abstract

    Green, A.; Curry, M. A.; Bach, P.; Mailankody, S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Long-term follow-up of CA209-004: A phase I dose-escalation study of combined nivolumab (NIVO) and ipilimumab (IPI) in patients with advanced melanoma
    Meeting Abstract

    Atkins, M. B.; Kirkwood, J. M.; Wolchok, J. D.; Callahan, M. K.; Kluger, H. M.; Postow, M. A.; Segal, N. H.; Lesokhin, A. M.; Balogh, A.; Re, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Melflufen in patients (pts) with relapsed/refractory multiple myeloma (RRMM) refractory to daratumumab (dara) and/or pomalidomide (pom) (OP-106)
    Meeting Abstract

    Richardson, P. G.; Oriol, A.; Larocca, A.; Otero, P. R.; Moreb, J.; Blade, J.; Hassoun, H.; Cavo, M.; Alegre, A.; Mazumder, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hematologic toxicities of apparent immune-related origins
    Book Section

    Chen, G. L.; Robert, C.; Lesokhin, A. M.
    In Ernstoff, M. S.; Puzanov, I.; Robert, C.; Diab, A.; Hersey, P. (Eds.) SITC's Guide to Managing Immunotherapy Toxicity (2019)

    Fulltext@MSK | Save
  • Monoclonal gammopathy-associated thrombotic microangiopathy
    Journal Article

    Yui, J. C.; Garceau, D.; Jhaveri, K. D.; Wanchoo, R.; Bijol, V.; Glezerman, I.; Hassoun, H.; Dispenzieri, A.; Russell, S. J.; Leung, N.
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
    Journal Article

    Huang, P. A.; Beedie, S. L.; Chau, C. H.; Venzon, D. J.; Gere, S.; Kazandjian, D.; Korde, N.; Mailankody, S.; Landgren, O.; Figg, W. D.
    Scientific Reports (2019)

    Fulltext@MSK | Save
  • Multiple myeloma, version 1.2020: Featured updates to the NCCN guidelines
    Guidelines

    Kumar, S. K.; Callander, N. S.; Hillengass, J.; Liedtke, M.; Baljevic, M.; Campagnaro, E.; Castillo, J. J.; Chandler, J. C.; Cornell, R. F.; Costello, C.; more...
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologics
    Review

    Anderson, K. C.; Landgren, O.; Arend, R. C.; Chou, J.; Jacobs, I. A.
    Future Oncology (2019)

    Fulltext@MSK | Save